Wedbush Securities’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-18,380
Closed -$198K 998
2019
Q1
$198K Sell
18,380
-6,975
-28% -$75.1K 0.02% 777
2018
Q4
$383K Buy
25,355
+1,900
+8% +$28.7K 0.05% 450
2018
Q3
$434K Buy
23,455
+10,225
+77% +$189K 0.05% 451
2018
Q2
$302K Buy
+13,230
New +$302K 0.04% 549